Rossari Biotech Reschedules Capacity Expansion at Subsidiaries for Phased Implementation
Rossari Biotech Limited has announced a revision to the timeline for its capacity expansion plans at its material subsidiaries, Unitop Chemicals Private Limited and Tristar Intermediates Private Limited.The company reported that the subsidiaries are currently re-evaluating the investment plan. This re-evaluation is being conducted in light of evolving business requirements and current market conditions.
Consequently, the implementation of the previously proposed capacity expansion project is being rescheduled. The expansion is now expected to be undertaken in a phased manner over the next two years.
Rossari Biotech Limited stated that while the timeline for the capacity addition is being modified, the overall strategic intent behind the investment remains unchanged.
ROSSARI Stock Price Movement
Rossari Biotech Limited shares today slipped by 0.70% to settle at ₹511.35 in post-market trading. The stock saw a total volume of 177,681 shares, trading within a range defined by a low of ₹506.55 and a high of ₹524.15.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.